These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 28521363)

  • 1. A Cisplatin Derivative Tetra-Pt(bpy) as an Oncotherapeutic Agent for Targeting ALT Cancer.
    Zheng XH; Nie X; Fang Y; Zhang Z; Xiao Y; Mao Z; Liu H; Ren J; Wang F; Xia L; Huang J; Zhao Y
    J Natl Cancer Inst; 2017 Oct; 109(10):. PubMed ID: 28521363
    [TBL] [Abstract][Full Text] [Related]  

  • 2. G-quadruplex stabilizer Tetra-Pt(bpy) disrupts telomere maintenance and impairs FAK-mediated migration of telomerase-positive cells.
    Shen Z; Zheng R; Yang H; Xing S; Jin X; Yan H; Zhu J; Mei Y; Lin F; Zheng X
    Int J Biol Macromol; 2022 Jul; 213():858-870. PubMed ID: 35697164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The different biological effects of TMPyP4 and cisplatin in the inflammatory microenvironment of osteosarcoma are attributed to G-quadruplex.
    Chen J; Jin X; Mei Y; Shen Z; Zhu J; Shi H; Wang M; Zheng X; Liang G
    Cell Prolif; 2021 Sep; 54(9):e13101. PubMed ID: 34296479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting telomerase activity by BIBR1532 as a therapeutic approach in germ cell tumors.
    Mueller S; Hartmann U; Mayer F; Balabanov S; Hartmann JT; Brummendorf TH; Bokemeyer C
    Invest New Drugs; 2007 Dec; 25(6):519-24. PubMed ID: 17534576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnosis and treatment of ALT tumors: is Trabectedin a new therapeutic option?
    Pompili L; Leonetti C; Biroccio A; Salvati E
    J Exp Clin Cancer Res; 2017 Dec; 36(1):189. PubMed ID: 29273061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Telomerase suppresses formation of ALT-associated single-stranded telomeric C-circles.
    Plantinga MJ; Pascarelli KM; Merkel AS; Lazar AJ; von Mehren M; Lev D; Broccoli D
    Mol Cancer Res; 2013 Jun; 11(6):557-67. PubMed ID: 23505069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selected ellipticine derivatives, known to target topoisomerase II, suppress the alternative lengthening of telomere (ALT) pathway in telomerase-negative cells.
    Zencir S; Hsieh MH; Hsu JS; Ergun Y; Chou GL; Li TK; Teng SC; Topcu Z
    J Cancer Res Clin Oncol; 2020 Jul; 146(7):1671-1676. PubMed ID: 32333143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topoisomerase II inhibition suppresses the proliferation of telomerase-negative cancers.
    Hsieh MH; Tsai CH; Lin CC; Li TK; Hung TW; Chang LT; Hsin LW; Teng SC
    Cell Mol Life Sci; 2015 May; 72(9):1825-37. PubMed ID: 25430478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel therapeutic strategies targeting telomere maintenance mechanisms in high-risk neuroblastoma.
    George SL; Parmar V; Lorenzi F; Marshall LV; Jamin Y; Poon E; Angelini P; Chesler L
    J Exp Clin Cancer Res; 2020 May; 39(1):78. PubMed ID: 32375866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. G-quadruplex Stabilization Fuels the ALT Pathway in ALT-positive Osteosarcoma Cells.
    Amato R; Valenzuela M; Berardinelli F; Salvati E; Maresca C; Leone S; Antoccia A; Sgura A
    Genes (Basel); 2020 Mar; 11(3):. PubMed ID: 32183119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The G-quadruplex-interactive molecule BRACO-19 inhibits tumor growth, consistent with telomere targeting and interference with telomerase function.
    Burger AM; Dai F; Schultes CM; Reszka AP; Moore MJ; Double JA; Neidle S
    Cancer Res; 2005 Feb; 65(4):1489-96. PubMed ID: 15735037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA methylation mediated up-regulation of TERRA non-coding RNA is coincident with elongated telomeres in the human placenta.
    Novakovic B; Napier CE; Vryer R; Dimitriadis E; Manuelpillai U; Sharkey A; Craig JM; Reddel RR; Saffery R
    Mol Hum Reprod; 2016 Nov; 22(11):791-799. PubMed ID: 27604461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platinum(II) phenanthroimidazole G-quadruplex ligand induces selective telomere shortening in A549 cancer cells.
    Mancini J; Rousseau P; Castor KJ; Sleiman HF; Autexier C
    Biochimie; 2016 Feb; 121():287-97. PubMed ID: 26724375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alternative lengthening of telomeres renders cancer cells hypersensitive to ATR inhibitors.
    Flynn RL; Cox KE; Jeitany M; Wakimoto H; Bryll AR; Ganem NJ; Bersani F; Pineda JR; Suvà ML; Benes CH; Haber DA; Boussin FD; Zou L
    Science; 2015 Jan; 347(6219):273-7. PubMed ID: 25593184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of p53 and/or AKT as a new therapeutic approach specifically targeting ALT cancers.
    Ge Y; Wu S; Zhang Z; Li X; Li F; Yan S; Liu H; Huang J; Zhao Y
    Protein Cell; 2019 Nov; 10(11):808-824. PubMed ID: 31115790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. G-quadruplex stabilizer 3,6-bis(1-methyl-4-vinylpyridinium)carbazole diiodide induces accelerated senescence and inhibits tumorigenic properties in cancer cells.
    Huang FC; Chang CC; Lou PJ; Kuo IC; Chien CW; Chen CT; Shieh FY; Chang TC; Lin JJ
    Mol Cancer Res; 2008 Jun; 6(6):955-64. PubMed ID: 18515756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ALTering Cancer by Triggering Telomere Replication Stress through the Stabilization of Promoter G-Quadruplex in
    Panda S; Roychowdhury T; Dutta A; Chakraborty S; Das T; Chatterjee S
    ACS Chem Biol; 2024 Jul; 19(7):1433-1439. PubMed ID: 38959478
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alternative lengthening of telomeres is characterized by high rates of telomeric exchange.
    Londoño-Vallejo JA; Der-Sarkissian H; Cazes L; Bacchetti S; Reddel RR
    Cancer Res; 2004 Apr; 64(7):2324-7. PubMed ID: 15059879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Telomerase- and alternative telomere lengthening-independent telomere stabilization in a metastasis-derived human non-small cell lung cancer cell line: effect of ectopic hTERT.
    Brachner A; Sasgary S; Pirker C; Rodgarkia C; Mikula M; Mikulits W; Bergmeister H; Setinek U; Wieser M; Chin SF; Caldas C; Micksche M; Cerni C; Berger W
    Cancer Res; 2006 Apr; 66(7):3584-92. PubMed ID: 16585183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alternative lengthening of telomeres is induced by telomerase inhibitors in Barrett's esophageal cells.
    Qin X; Qi B; Zhao B
    Oncol Rep; 2013 Apr; 29(4):1399-404. PubMed ID: 23338150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.